Comparative pharmacokinetics of the main active components in normal and ulcerative colitis rats after oral administration of Zingiberis Rhizoma–Ginseng Radix et Rhizoma herb pair and its single herb extracts by LC–MS/MS
Zingiberis Rhizoma and Ginseng Radix et Rhizoma are usually used together for the treatment of ulcerative colitis in clinical practices. However, their compatibility mechanism remains unclear. In this study, a rapid and sensitive liquid chromatography with tandem mass spectrometry method was develop...
Saved in:
| Published in | Journal of separation science Vol. 45; no. 13; pp. 2228 - 2238 |
|---|---|
| Main Authors | , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Germany
Wiley Subscription Services, Inc
01.07.2022
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Zingiberis Rhizoma and Ginseng Radix et Rhizoma are usually used together for the treatment of ulcerative colitis in clinical practices. However, their compatibility mechanism remains unclear. In this study, a rapid and sensitive liquid chromatography with tandem mass spectrometry method was developed for simultaneous quantification of ginsenoside Re, ginsenoside Rg1, ginsenoside Rb1, and 6‐gingerol in rat plasma after oral administration of Zingiberis Rhizoma–Ginseng Radix et Rhizoma herb pair and its single herb extracts. The calibration curves exhibited good linearity, with correlation coefficients of more than 0.993. The precision deviations of intra‐ and interday analysis were within 10.66%, and accuracy error ranged from −12.74 to 11.56%. The average recoveries of analytes were higher than 76.60% and the matrix effects were minimal. Thus, the validated method was successfully applied to a pharmacokinetic study of four ingredients in normal and ulcerative colitis rat plasma. The results indicated that the pharmacokinetic parameters of four analytes in normal and model groups showed significant differences. The larger exposure (the mean AUC0‐t of ginsenoside Re, ginsenoside Rg1, ginsenoside Rb1, and 6‐gingerol were increased by 50.93, 141.90, 3.68, and 37.25%, respectively) and slower elimination (the CLz/F of ginsenoside Re, ginsenoside Rg1, and 6‐gingerol were decreased by 52.94, 83.64, and 32.18%, respectively) were observed in ulcerative colitis rats. Furthermore, compared with single herbs, the analytes in rat plasma after oral administration of combined extracts presented relatively high systemic exposure levels with AUC0‐t > 2000 h·ng/mL and Cmax > 200 ng/mL. Collectively, the differences of pharmacokinetic characteristics revealed the synergistic effect of Zingiberis Rhizoma–Ginseng Radix et Rhizoma herb pair, which provided a valuable and reliable basis for its clinical application in the treatment of ulcerative colitis. |
|---|---|
| AbstractList | Zingiberis Rhizoma and Ginseng Radix et Rhizoma are usually used together for the treatment of ulcerative colitis in clinical practices. However, their compatibility mechanism remains unclear. In this study, a rapid and sensitive liquid chromatography with tandem mass spectrometry method was developed for simultaneous quantification of ginsenoside Re, ginsenoside Rg1, ginsenoside Rb1, and 6‐gingerol in rat plasma after oral administration of Zingiberis Rhizoma–Ginseng Radix et Rhizoma herb pair and its single herb extracts. The calibration curves exhibited good linearity, with correlation coefficients of more than 0.993. The precision deviations of intra‐ and interday analysis were within 10.66%, and accuracy error ranged from −12.74 to 11.56%. The average recoveries of analytes were higher than 76.60% and the matrix effects were minimal. Thus, the validated method was successfully applied to a pharmacokinetic study of four ingredients in normal and ulcerative colitis rat plasma. The results indicated that the pharmacokinetic parameters of four analytes in normal and model groups showed significant differences. The larger exposure (the mean AUC₀‐ₜ of ginsenoside Re, ginsenoside Rg1, ginsenoside Rb1, and 6‐gingerol were increased by 50.93, 141.90, 3.68, and 37.25%, respectively) and slower elimination (the CLz/F of ginsenoside Re, ginsenoside Rg1, and 6‐gingerol were decreased by 52.94, 83.64, and 32.18%, respectively) were observed in ulcerative colitis rats. Furthermore, compared with single herbs, the analytes in rat plasma after oral administration of combined extracts presented relatively high systemic exposure levels with AUC₀‐ₜ > 2000 h·ng/mL and Cₘₐₓ > 200 ng/mL. Collectively, the differences of pharmacokinetic characteristics revealed the synergistic effect of Zingiberis Rhizoma–Ginseng Radix et Rhizoma herb pair, which provided a valuable and reliable basis for its clinical application in the treatment of ulcerative colitis. Zingiberis Rhizoma and Ginseng Radix et Rhizoma are usually used together for the treatment of ulcerative colitis in clinical practices. However, their compatibility mechanism remains unclear. In this study, a rapid and sensitive liquid chromatography with tandem mass spectrometry method was developed for simultaneous quantification of ginsenoside Re, ginsenoside Rg1, ginsenoside Rb1, and 6‐gingerol in rat plasma after oral administration of Zingiberis Rhizoma–Ginseng Radix et Rhizoma herb pair and its single herb extracts. The calibration curves exhibited good linearity, with correlation coefficients of more than 0.993. The precision deviations of intra‐ and interday analysis were within 10.66%, and accuracy error ranged from −12.74 to 11.56%. The average recoveries of analytes were higher than 76.60% and the matrix effects were minimal. Thus, the validated method was successfully applied to a pharmacokinetic study of four ingredients in normal and ulcerative colitis rat plasma. The results indicated that the pharmacokinetic parameters of four analytes in normal and model groups showed significant differences. The larger exposure (the mean AUC0‐t of ginsenoside Re, ginsenoside Rg1, ginsenoside Rb1, and 6‐gingerol were increased by 50.93, 141.90, 3.68, and 37.25%, respectively) and slower elimination (the CLz/F of ginsenoside Re, ginsenoside Rg1, and 6‐gingerol were decreased by 52.94, 83.64, and 32.18%, respectively) were observed in ulcerative colitis rats. Furthermore, compared with single herbs, the analytes in rat plasma after oral administration of combined extracts presented relatively high systemic exposure levels with AUC0‐t > 2000 h·ng/mL and Cmax > 200 ng/mL. Collectively, the differences of pharmacokinetic characteristics revealed the synergistic effect of Zingiberis Rhizoma–Ginseng Radix et Rhizoma herb pair, which provided a valuable and reliable basis for its clinical application in the treatment of ulcerative colitis. Zingiberis Rhizoma and Ginseng Radix et Rhizoma are usually used together for the treatment of ulcerative colitis in clinical practices. However, their compatibility mechanism remains unclear. In this study, a rapid and sensitive liquid chromatography with tandem mass spectrometry method was developed for simultaneous quantification of ginsenoside Re, ginsenoside Rg1, ginsenoside Rb1, and 6-gingerol in rat plasma after oral administration of Zingiberis Rhizoma-Ginseng Radix et Rhizoma herb pair and its single herb extracts. The calibration curves exhibited good linearity, with correlation coefficients of more than 0.993. The precision deviations of intra- and interday analysis were within 10.66%, and accuracy error ranged from -12.74 to 11.56%. The average recoveries of analytes were higher than 76.60% and the matrix effects were minimal. Thus, the validated method was successfully applied to a pharmacokinetic study of four ingredients in normal and ulcerative colitis rat plasma. The results indicated that the pharmacokinetic parameters of four analytes in normal and model groups showed significant differences. The larger exposure (the mean AUC0-t of ginsenoside Re, ginsenoside Rg1, ginsenoside Rb1, and 6-gingerol were increased by 50.93, 141.90, 3.68, and 37.25%, respectively) and slower elimination (the CLz/F of ginsenoside Re, ginsenoside Rg1, and 6-gingerol were decreased by 52.94, 83.64, and 32.18%, respectively) were observed in ulcerative colitis rats. Furthermore, compared with single herbs, the analytes in rat plasma after oral administration of combined extracts presented relatively high systemic exposure levels with AUC0-t > 2000 h·ng/mL and Cmax > 200 ng/mL. Collectively, the differences of pharmacokinetic characteristics revealed the synergistic effect of Zingiberis Rhizoma-Ginseng Radix et Rhizoma herb pair, which provided a valuable and reliable basis for its clinical application in the treatment of ulcerative colitis.Zingiberis Rhizoma and Ginseng Radix et Rhizoma are usually used together for the treatment of ulcerative colitis in clinical practices. However, their compatibility mechanism remains unclear. In this study, a rapid and sensitive liquid chromatography with tandem mass spectrometry method was developed for simultaneous quantification of ginsenoside Re, ginsenoside Rg1, ginsenoside Rb1, and 6-gingerol in rat plasma after oral administration of Zingiberis Rhizoma-Ginseng Radix et Rhizoma herb pair and its single herb extracts. The calibration curves exhibited good linearity, with correlation coefficients of more than 0.993. The precision deviations of intra- and interday analysis were within 10.66%, and accuracy error ranged from -12.74 to 11.56%. The average recoveries of analytes were higher than 76.60% and the matrix effects were minimal. Thus, the validated method was successfully applied to a pharmacokinetic study of four ingredients in normal and ulcerative colitis rat plasma. The results indicated that the pharmacokinetic parameters of four analytes in normal and model groups showed significant differences. The larger exposure (the mean AUC0-t of ginsenoside Re, ginsenoside Rg1, ginsenoside Rb1, and 6-gingerol were increased by 50.93, 141.90, 3.68, and 37.25%, respectively) and slower elimination (the CLz/F of ginsenoside Re, ginsenoside Rg1, and 6-gingerol were decreased by 52.94, 83.64, and 32.18%, respectively) were observed in ulcerative colitis rats. Furthermore, compared with single herbs, the analytes in rat plasma after oral administration of combined extracts presented relatively high systemic exposure levels with AUC0-t > 2000 h·ng/mL and Cmax > 200 ng/mL. Collectively, the differences of pharmacokinetic characteristics revealed the synergistic effect of Zingiberis Rhizoma-Ginseng Radix et Rhizoma herb pair, which provided a valuable and reliable basis for its clinical application in the treatment of ulcerative colitis. Zingiberis Rhizoma and Ginseng Radix et Rhizoma are usually used together for the treatment of ulcerative colitis in clinical practices. However, their compatibility mechanism remains unclear. In this study, a rapid and sensitive liquid chromatography with tandem mass spectrometry method was developed for simultaneous quantification of ginsenoside Re, ginsenoside Rg1, ginsenoside Rb1, and 6‐gingerol in rat plasma after oral administration of Zingiberis Rhizoma–Ginseng Radix et Rhizoma herb pair and its single herb extracts. The calibration curves exhibited good linearity, with correlation coefficients of more than 0.993. The precision deviations of intra‐ and interday analysis were within 10.66%, and accuracy error ranged from −12.74 to 11.56%. The average recoveries of analytes were higher than 76.60% and the matrix effects were minimal. Thus, the validated method was successfully applied to a pharmacokinetic study of four ingredients in normal and ulcerative colitis rat plasma. The results indicated that the pharmacokinetic parameters of four analytes in normal and model groups showed significant differences. The larger exposure (the mean AUC 0‐t of ginsenoside Re, ginsenoside Rg1, ginsenoside Rb1, and 6‐gingerol were increased by 50.93, 141.90, 3.68, and 37.25%, respectively) and slower elimination (the CL z/F of ginsenoside Re, ginsenoside Rg1, and 6‐gingerol were decreased by 52.94, 83.64, and 32.18%, respectively) were observed in ulcerative colitis rats. Furthermore, compared with single herbs, the analytes in rat plasma after oral administration of combined extracts presented relatively high systemic exposure levels with AUC 0‐t > 2000 h·ng/mL and C max > 200 ng/mL. Collectively, the differences of pharmacokinetic characteristics revealed the synergistic effect of Zingiberis Rhizoma–Ginseng Radix et Rhizoma herb pair, which provided a valuable and reliable basis for its clinical application in the treatment of ulcerative colitis. Zingiberis Rhizoma and Ginseng Radix et Rhizoma are usually used together for the treatment of ulcerative colitis in clinical practices. However, their compatibility mechanism remains unclear. In this study, a rapid and sensitive liquid chromatography with tandem mass spectrometry method was developed for simultaneous quantification of ginsenoside Re, ginsenoside Rg1, ginsenoside Rb1, and 6-gingerol in rat plasma after oral administration of Zingiberis Rhizoma-Ginseng Radix et Rhizoma herb pair and its single herb extracts. The calibration curves exhibited good linearity, with correlation coefficients of more than 0.993. The precision deviations of intra- and interday analysis were within 10.66%, and accuracy error ranged from -12.74 to 11.56%. The average recoveries of analytes were higher than 76.60% and the matrix effects were minimal. Thus, the validated method was successfully applied to a pharmacokinetic study of four ingredients in normal and ulcerative colitis rat plasma. The results indicated that the pharmacokinetic parameters of four analytes in normal and model groups showed significant differences. The larger exposure (the mean AUC of ginsenoside Re, ginsenoside Rg1, ginsenoside Rb1, and 6-gingerol were increased by 50.93, 141.90, 3.68, and 37.25%, respectively) and slower elimination (the CLz/F of ginsenoside Re, ginsenoside Rg1, and 6-gingerol were decreased by 52.94, 83.64, and 32.18%, respectively) were observed in ulcerative colitis rats. Furthermore, compared with single herbs, the analytes in rat plasma after oral administration of combined extracts presented relatively high systemic exposure levels with AUC > 2000 h·ng/mL and C > 200 ng/mL. Collectively, the differences of pharmacokinetic characteristics revealed the synergistic effect of Zingiberis Rhizoma-Ginseng Radix et Rhizoma herb pair, which provided a valuable and reliable basis for its clinical application in the treatment of ulcerative colitis. |
| Author | Qian, Dawei Wan, Yue Li, Huifang Yang, Lei Li, Wenwen Dong, Zhiling Zhu, Ke Jiang, Shu Duan, Jinao |
| Author_xml | – sequence: 1 givenname: Yue surname: Wan fullname: Wan, Yue organization: Nanjing University of Chinese Medicine – sequence: 2 givenname: Zhiling surname: Dong fullname: Dong, Zhiling organization: Nanjing University of Chinese Medicine – sequence: 3 givenname: Huifang surname: Li fullname: Li, Huifang organization: Nanjing University of Chinese Medicine – sequence: 4 givenname: Lei surname: Yang fullname: Yang, Lei organization: Nanjing University of Chinese Medicine – sequence: 5 givenname: Wenwen surname: Li fullname: Li, Wenwen organization: Nanjing University of Chinese Medicine – sequence: 6 givenname: Ke surname: Zhu fullname: Zhu, Ke organization: Nanjing University of Chinese Medicine – sequence: 7 givenname: Shu surname: Jiang fullname: Jiang, Shu email: jiangshu2020@126.com organization: Nanjing University of Chinese Medicine – sequence: 8 givenname: Dawei surname: Qian fullname: Qian, Dawei organization: Nanjing University of Chinese Medicine – sequence: 9 givenname: Jinao surname: Duan fullname: Duan, Jinao email: dja@njutcm.edu.cn organization: Nanjing University of Chinese Medicine |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35474281$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkstu1DAUhiNURC-wZYkssWEzU9uxHWeJRlBAUyF1YMMmcpyTjofEHuwMdLrqO_CCiCfhzK2LSqjywrfv_499zjnNjnzwkGUvGR0zSvn5IiU75pQziqN8kp0wxeSozJk4ul9TdZydprSglBW6pM-y41yKQnDNTrI_k9AvTTSD-wlkOTexNzZ8dx4GZxMJLRnmQHrjPDF2y1jk8Ql-SAQPfUBBR4xvyKqzsPexoXODSwS3iZh2gEhC3GBN77xLwwYLfuP-zflrV0NE-GrubkNv_t79vnA-gb8mV6ZxNwSGwxWZQ6zJ0ri4DejQPKG-g90F3KCxxcN6TaYT9LmcnV_OnmdPW9MleLGfz7Kv7999mXwYTT9ffJy8nY6swMSNOFChaFnWQpq8kFDKvNC5Yqa1ra6ltphKiUuQwgphVKHaQuuWN9I0OWvy_Cx7s_NdxvBjBWmoepcsdJ3xEFap4gXTvFRCq8dRJRWWlHON6OsH6CKsosePIFVKphlnEqlXe2pV99BUy-h6E9fVocwIiB1gY0gpQltZN2yLgClzXcVotemmatNN1X03oWz8QHZw_q9gH-eX62D9CF19ms0mhcrL_B_O9-Eu |
| CitedBy_id | crossref_primary_10_1002_sscp_202400162 crossref_primary_10_1002_sscp_202400166 crossref_primary_10_1016_j_ijpharm_2025_125375 crossref_primary_10_1016_j_matdes_2024_113291 crossref_primary_10_1016_j_jchromb_2024_124193 crossref_primary_10_1016_j_jpba_2023_115431 crossref_primary_10_1016_j_jep_2023_117010 |
| Cites_doi | 10.1002/jssc.201901250 10.1080/00498254.2019.1682715 10.1039/D0SC06288J 10.3390/ijms22063076 10.3390/jcm8101574 10.1016/j.apsb.2021.01.009 10.1002/ptr.6858 10.1016/j.jep.2020.112951 10.1016/S1875-5364(19)30012-3 10.21037/atm.2020.03.141 10.3390/molecules24132365 10.1021/jf301372g 10.3390/pharmaceutics12020180 10.1016/j.carbpol.2020.117189 10.1371/journal.pone.0108386 10.1002/ptr.5871 10.1002/jssc.201701042 10.1016/j.cgh.2020.01.008 10.1002/jssc.201600606 10.1007/s00253-020-10665-1 10.1371/journal.pone.0098717 10.2147/DDDT.S257020 10.1039/D0FO02834G 10.1016/j.jpba.2019.112874 10.1002/ptr.6730 10.3389/fphar.2020.00933 10.1007/s11356-020-10306-0 10.1016/j.jchromb.2014.05.036 10.1002/bmc.4521 10.1016/S0140-6736(16)32126-2 10.1111/1541-4337.12652 10.3390/molecules24224065 10.1016/j.jep.2021.114197 10.3390/foods9081136 10.1016/j.ejphar.2022.174742 10.3390/pharmaceutics12020128 10.1371/journal.pone.0194536 10.1002/jssc.202100061 |
| ContentType | Journal Article |
| Copyright | 2022 Wiley‐VCH GmbH. 2022 Wiley-VCH GmbH. |
| Copyright_xml | – notice: 2022 Wiley‐VCH GmbH. – notice: 2022 Wiley-VCH GmbH. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7U5 8FD L7M 7X8 7S9 L.6 |
| DOI | 10.1002/jssc.202101019 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Solid State and Superconductivity Abstracts Technology Research Database Advanced Technologies Database with Aerospace MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Technology Research Database Advanced Technologies Database with Aerospace Solid State and Superconductivity Abstracts MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
| DatabaseTitleList | AGRICOLA Technology Research Database MEDLINE - Academic CrossRef MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Engineering Chemistry |
| EISSN | 1615-9314 |
| EndPage | 2238 |
| ExternalDocumentID | 35474281 10_1002_jssc_202101019 JSSC7639 |
| Genre | article Journal Article |
| GrantInformation_xml | – fundername: Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization funderid: ZDXM‐3‐9 – fundername: Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization grantid: ZDXM-3-9 |
| GroupedDBID | --- .3N .GA .Y3 05W 0R~ 10A 1L6 1OC 31~ 33P 3SF 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52S 52T 52U 52W 52X 53G 5GY 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A03 AAESR AAEVG AAHBH AAHHS AAHQN AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCUV ABDBF ABIJN ABJNI ABPVW ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACIWK ACPOU ACRPL ACUHS ACXBN ACXQS ACYXJ ADBBV ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFPM AFGKR AFPWT AFWVQ AFZJQ AHBTC AI. AITYG AIURR AIWBW AJBDE AJXKR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ATUGU AUFTA AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMNLL BMXJE BNHUX BROTX BRXPI BY8 CS3 D-E D-F DCZOG DPXWK DR2 DRFUL DRSTM DU5 EBD EJD F00 F01 F04 F5P FEDTE G-S G.N GNP GODZA H.T H.X HGLYW HHZ HVGLF HZ~ IX1 J0M JPC KQQ LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRSTM MSFUL MSSTM MXFUL MXSTM N04 N05 N9A NF~ NNB O66 O9- OIG P2P P2W P2X P4D PQQKQ Q.N Q11 QB0 QRW R.K RNS ROL RWI RX1 RYL SUPJJ TUS UB1 UPT VH1 W8V W99 WBFHL WBKPD WIH WIK WJL WOHZO WXSBR WYISQ XG1 XPP XV2 YQT ~IA ~KM ~WT AAYXX ADMLS AEYWJ AGHNM AGQPQ AGYGG CITATION AAMMB AEFGJ AGXDD AIDQK AIDYY CGR CUY CVF ECM EIF NPM 1OB 7U5 8FD L7M 7X8 7S9 L.6 |
| ID | FETCH-LOGICAL-c4019-2e046099b45a375e95378361afcf8b58c6155cf8e54c44a676f788f2d5ad31d33 |
| IEDL.DBID | DR2 |
| ISSN | 1615-9306 1615-9314 |
| IngestDate | Fri Jul 11 18:35:48 EDT 2025 Fri Jul 11 05:42:21 EDT 2025 Wed Aug 13 04:37:39 EDT 2025 Mon Jul 21 06:04:41 EDT 2025 Thu Apr 24 22:56:20 EDT 2025 Tue Jul 01 01:26:56 EDT 2025 Wed Jan 22 16:23:52 EST 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 13 |
| Keywords | pharmacokinetics herb pair liquid chromatography ulcerative colitis |
| Language | English |
| License | 2022 Wiley-VCH GmbH. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c4019-2e046099b45a375e95378361afcf8b58c6155cf8e54c44a676f788f2d5ad31d33 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| PMID | 35474281 |
| PQID | 2695181215 |
| PQPubID | 105495 |
| PageCount | 11 |
| ParticipantIDs | proquest_miscellaneous_2718296486 proquest_miscellaneous_2656202228 proquest_journals_2695181215 pubmed_primary_35474281 crossref_citationtrail_10_1002_jssc_202101019 crossref_primary_10_1002_jssc_202101019 wiley_primary_10_1002_jssc_202101019_JSSC7639 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | July 2022 2022-07-00 2022-Jul 20220701 |
| PublicationDateYYYYMMDD | 2022-07-01 |
| PublicationDate_xml | – month: 07 year: 2022 text: July 2022 |
| PublicationDecade | 2020 |
| PublicationPlace | Germany |
| PublicationPlace_xml | – name: Germany – name: Weinheim |
| PublicationTitle | Journal of separation science |
| PublicationTitleAlternate | J Sep Sci |
| PublicationYear | 2022 |
| Publisher | Wiley Subscription Services, Inc |
| Publisher_xml | – name: Wiley Subscription Services, Inc |
| References | 2019; 8 2012; 60 2021; 20 2021; 44 2021; 22 2020; 261 2019; 33 2019; 17 2020; 104 2022; 917 2020; 14 2018; 41 2020; 12 2020; 34 2020; 11 2016; 39 2020; 18 2020; 8 2021; 35 2017; 31 2021; 12 2021; 11 2020; 75 2021; 277 2020; 50 2019; 24 2020; 9 2020; 27 2014; 15 2020; 177 2021; 254 2020; 43 2014; 9 2017; 389 2018; 13 e_1_2_8_28_1 e_1_2_8_29_1 e_1_2_8_24_1 e_1_2_8_25_1 e_1_2_8_26_1 e_1_2_8_27_1 e_1_2_8_3_1 e_1_2_8_2_1 e_1_2_8_5_1 e_1_2_8_4_1 e_1_2_8_7_1 e_1_2_8_6_1 e_1_2_8_9_1 e_1_2_8_8_1 e_1_2_8_20_1 e_1_2_8_21_1 e_1_2_8_22_1 e_1_2_8_23_1 e_1_2_8_40_1 e_1_2_8_17_1 e_1_2_8_18_1 e_1_2_8_39_1 e_1_2_8_19_1 e_1_2_8_13_1 e_1_2_8_36_1 e_1_2_8_35_1 e_1_2_8_15_1 e_1_2_8_38_1 e_1_2_8_16_1 e_1_2_8_37_1 Tian Y (e_1_2_8_14_1) 2020; 75 e_1_2_8_32_1 e_1_2_8_10_1 e_1_2_8_31_1 e_1_2_8_11_1 e_1_2_8_34_1 e_1_2_8_12_1 e_1_2_8_33_1 e_1_2_8_30_1 |
| References_xml | – volume: 27 start-page: 45008 year: 2020 end-page: 45017 article-title: Ginseng attenuates fipronil‐induced hepatorenal toxicity via its antioxidant, anti‐apoptotic, and anti‐inflammatory activities in rats publication-title: Environ Sci Pollut Res Int – volume: 254 year: 2021 article-title: Polysaccharides from natural resources exhibit great potential in the treatment of ulcerative colitis: a review publication-title: Carbohydr Polym – volume: 34 start-page: 2843 year: 2020 end-page: 2856 article-title: Clinical trials on pain lowering effect of ginger: a narrative review publication-title: Phytother Res – volume: 39 start-page: 4096 year: 2016 end-page: 4106 article-title: Comparative analysis of the main bioactive components of Xin‐Sheng‐Hua granule and its single herbs by ultrahigh performance liquid chromatography with tandem mass spectrometry publication-title: J Sep Sci – volume: 9 year: 2014 article-title: Modulation of cytochrome P450 metabolism and transport across intestinal epithelial barrier by ginger biophenolics publication-title: PLoS One – volume: 17 start-page: 81 year: 2019 end-page: 102 article-title: Progress in active compounds effective on ulcerative colitis from Chinese medicines publication-title: Chin J Nat Med – volume: 8 start-page: 442 year: 2020 article-title: The effect of 6‐gingerol on inflammatory response and Th17/Treg balance in DSS‐induced ulcerative colitis mice publication-title: Ann Transl Med – volume: 12 start-page: 6293 year: 2021 end-page: 6306 article-title: Active participation of membrane lipids in inhibition of multidrug transporter P‐glycoprotein publication-title: Chem Sci – volume: 24 start-page: 4065 year: 2019 article-title: Development of a validated UPLC‐MS/MS method for analyzing major ginseng saponins from various ginseng species publication-title: Molecules – volume: 24 start-page: 2365 year: 2019 article-title: Recent advances in biotransformation of saponins publication-title: Molecules – volume: 35 start-page: 711 year: 2021 end-page: 742 article-title: Ginger ( Rosc.) and its bioactive components are potential resources for health beneficial agents publication-title: Phytother Res – volume: 31 start-page: 1427 year: 2017 end-page: 1432 article-title: Therapeutic effects of 6‐gingerol, 8‐gingerol, and 10‐gingerol on dextran sulfate sodium‐induced acute ulcerative colitis in rats publication-title: Phytother Res – volume: 917 year: 2022 article-title: Ginsenoside Rg1 ameliorated experimental colitis by regulating the balance of M1/M2 macrophage polarization and the homeostasis of intestinal flora publication-title: Eur J Pharmacol – volume: 13 year: 2018 article-title: MDR1 gene polymorphisms are associated with ulcerative colitis in a cohort of Serbian patients with inflammatory bowel disease publication-title: PLoS One – volume: 9 start-page: 1136 year: 2020 article-title: Simultaneous determination of 6‐shogaol and 6‐gingerol in various ginger ( Roscoe) extracts and commercial formulations using a green RP‐HPTLC‐densitometry method publication-title: Foods – volume: 12 start-page: 180 year: 2020 article-title: Large volume direct injection ultra‐high performance liquid chromatography‐tandem mass spectrometry‐based comparative pharmacokinetic study between single and combinatory uses of extract and notoginseng total saponins publication-title: Pharmaceutics – volume: 75 start-page: 147 year: 2020 end-page: 150 article-title: Antitumor activity of ginsenoside Rd in gastric cancer via up‐regulation of caspase‐3 and caspase‐9 publication-title: Pharmazie – volume: 389 start-page: 1756 year: 2017 end-page: 1770 article-title: Ulcerative colitis publication-title: Lancet. – volume: 14 start-page: 2877 year: 2020 end-page: 2888 article-title: Pharmacokinetic analysis of Huangqi Guizhi Wuwu decoction on blood and brain tissue in rats with normal and cerebral ischemia‐reperfusion injury by microdialysis with HPLC‐MS/MS publication-title: Drug Des Devel Ther. – volume: 261 year: 2020 article-title: Intestinal anti‐inflammatory effects of Fuzi‐Ganjiang herb pair against DSS‐induced ulcerative colitis in mice publication-title: J Ethnopharmacol – volume: 33 year: 2019 article-title: Comparative pharmacokinetics of nine major bioactive components in normal and ulcerative colitis rats after oral administration of Lizhong decoction extracts by UPLC‐TQ‐MS/MS publication-title: Biomed Chromatogr – volume: 41 start-page: 1512 year: 2018 end-page: 1523 article-title: Analysis of bioactive components and multi‐component pharmacokinetics of saponins from the leaves of in rat plasma after oral administration by LC‐MS/MS publication-title: J Sep Sci – volume: 11 start-page: 933 year: 2020 article-title: Multi‐component comparative pharmacokinetics in rats after oral administration of extract, naringin, neohesperidin, and naringin‐neohesperidin publication-title: Front Pharmacol – volume: 12 start-page: 128 year: 2020 article-title: Synergistic mechanisms of constituents in herbal extracts during intestinal absorption: focus on natural occurring nanoparticles publication-title: Pharmaceutics – volume: 44 start-page: 3158 year: 2021 end-page: 3166 article-title: Mass spectrometry‐based urinary metabolomics for exploring the treatment effects of herb pair on Alzheimer's disease in rats publication-title: J Sep Sci – volume: 18 start-page: 2179 year: 2020 end-page: 2191 article-title: First‐ and second‐line pharmacotherapies for patients with moderate to severely active ulcerative colitis: an updated network meta‐analysis publication-title: Clin Gastroenterol Hepatol – volume: 22 start-page: 3076 year: 2021 article-title: The interplay between immune system and microbiota in inflammatory bowel disease: a narrative review publication-title: Int J Mol Sci – volume: 277 year: 2021 article-title: Exploration of the potential mechanism of decoction for the effects on TNBS‐induced ulcerative colitis rats with the assistance of network pharmacology analysis publication-title: J Ethnopharmacol – volume: 8 start-page: 1574 year: 2019 article-title: Preclinical study for new pharmacological approaches in inflammatory bowel disease: a systematic review of chronic model of TNBS‐induced colitis publication-title: J Clin Med – volume: 20 start-page: 225 year: 2021 end-page: 251 article-title: Citrus flavonoids and the intestinal barrier: interactions and effects publication-title: Compr Rev Food Sci Food Saf. – volume: 60 start-page: 9595 year: 2012 end-page: 9602 article-title: Ginsenoside Re ameliorates inflammation by inhibiting the binding of lipopolysaccharide to TLR4 on macrophages publication-title: J Agric Food Chem – volume: 15 start-page: 29 year: 2014 end-page: 39 article-title: Simultaneous determination of bioactive components of Sinensis‐ Alba herb couple in rat plasma and tissues by UPLC‐MS/MS and its application to pharmacokinetics and tissue distribution publication-title: J Chromatogr B – volume: 11 start-page: 1213 year: 2021 end-page: 1226 article-title: Gut microbiota mediates the absorption of FLZ, a new drug for Parkinson's disease treatment publication-title: Acta Pharm Sin B – volume: 9 year: 2014 article-title: Pharmacokinetic compatibility of ginsenosides and schisandra lignans in Shengmai‐san: from the perspective of P‐glycoprotein publication-title: PLoS One – volume: 43 start-page: 2349 year: 2020 end-page: 2362 article-title: Effect of co‐administration of volatile oil on pharmacokinetic fate of xanthotoxol, oxypeucedanin hydrate, and byakangelicin from in rat publication-title: J Sep Sci – volume: 50 start-page: 713 year: 2020 end-page: 721 article-title: Comparative pharmacokinetics of verapamil and norverapamil in normal and ulcerative colitis rats after oral administration of low and high dose verapamil by UPLC‐MS/MS publication-title: Xenobiotica – volume: 104 start-page: 5999 year: 2020 end-page: 6012 article-title: Lizhong decoction ameliorates ulcerative colitis in mice via modulating gut microbiota and its metabolites publication-title: Appl Microbiol Biotechnol – volume: 12 start-page: 519 year: 2021 end-page: 542 article-title: A recent update on the multifaceted health benefits associated with ginger and its bioactive components publication-title: Food Funct – volume: 177 year: 2020 article-title: Comparative pharmacokinetic study of the components in Miq.‐ (Turcz.) Baill. herb pair and its single herb between normal and Alzheimer's disease rats by UPLC‐MS/MS publication-title: J Pharm Biomed Anal – ident: e_1_2_8_34_1 doi: 10.1002/jssc.201901250 – ident: e_1_2_8_37_1 doi: 10.1080/00498254.2019.1682715 – ident: e_1_2_8_35_1 doi: 10.1039/D0SC06288J – ident: e_1_2_8_39_1 doi: 10.3390/ijms22063076 – ident: e_1_2_8_25_1 doi: 10.3390/jcm8101574 – ident: e_1_2_8_27_1 doi: 10.1016/j.apsb.2021.01.009 – ident: e_1_2_8_9_1 doi: 10.1002/ptr.6858 – ident: e_1_2_8_8_1 doi: 10.1016/j.jep.2020.112951 – ident: e_1_2_8_5_1 doi: 10.1016/S1875-5364(19)30012-3 – ident: e_1_2_8_18_1 doi: 10.21037/atm.2020.03.141 – ident: e_1_2_8_32_1 doi: 10.3390/molecules24132365 – ident: e_1_2_8_20_1 doi: 10.1021/jf301372g – ident: e_1_2_8_28_1 doi: 10.3390/pharmaceutics12020180 – ident: e_1_2_8_2_1 doi: 10.1016/j.carbpol.2020.117189 – ident: e_1_2_8_29_1 doi: 10.1371/journal.pone.0108386 – ident: e_1_2_8_17_1 doi: 10.1002/ptr.5871 – ident: e_1_2_8_23_1 doi: 10.1002/jssc.201701042 – ident: e_1_2_8_4_1 doi: 10.1016/j.cgh.2020.01.008 – ident: e_1_2_8_22_1 doi: 10.1002/jssc.201600606 – ident: e_1_2_8_15_1 doi: 10.1007/s00253-020-10665-1 – ident: e_1_2_8_33_1 doi: 10.1371/journal.pone.0098717 – ident: e_1_2_8_31_1 doi: 10.2147/DDDT.S257020 – ident: e_1_2_8_10_1 doi: 10.1039/D0FO02834G – ident: e_1_2_8_40_1 doi: 10.1016/j.jpba.2019.112874 – ident: e_1_2_8_11_1 doi: 10.1002/ptr.6730 – ident: e_1_2_8_30_1 doi: 10.3389/fphar.2020.00933 – volume: 75 start-page: 147 year: 2020 ident: e_1_2_8_14_1 article-title: Antitumor activity of ginsenoside Rd in gastric cancer via up‐regulation of caspase‐3 and caspase‐9 publication-title: Pharmazie – ident: e_1_2_8_13_1 doi: 10.1007/s11356-020-10306-0 – ident: e_1_2_8_26_1 doi: 10.1016/j.jchromb.2014.05.036 – ident: e_1_2_8_24_1 doi: 10.1002/bmc.4521 – ident: e_1_2_8_3_1 doi: 10.1016/S0140-6736(16)32126-2 – ident: e_1_2_8_38_1 doi: 10.1111/1541-4337.12652 – ident: e_1_2_8_12_1 doi: 10.3390/molecules24224065 – ident: e_1_2_8_16_1 doi: 10.1016/j.jep.2021.114197 – ident: e_1_2_8_21_1 doi: 10.3390/foods9081136 – ident: e_1_2_8_19_1 doi: 10.1016/j.ejphar.2022.174742 – ident: e_1_2_8_6_1 doi: 10.3390/pharmaceutics12020128 – ident: e_1_2_8_36_1 doi: 10.1371/journal.pone.0194536 – ident: e_1_2_8_7_1 doi: 10.1002/jssc.202100061 |
| SSID | ssj0017890 |
| Score | 2.38893 |
| Snippet | Zingiberis Rhizoma and Ginseng Radix et Rhizoma are usually used together for the treatment of ulcerative colitis in clinical practices. However, their... |
| SourceID | proquest pubmed crossref wiley |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 2228 |
| SubjectTerms | Administration, Oral Animals chemical species Chromatography, High Pressure Liquid - methods Chromatography, Liquid Colitis, Ulcerative - drug therapy Correlation coefficients Drugs, Chinese Herbal - analysis Gingerol ginsenosides herb pair Herbs Inflammatory bowel disease Liquid chromatography Mass spectrometry Oral administration Panax Panax - chemistry Pharmacokinetics Pharmacology Plant Extracts Rats rhizomes separation synergism Synergistic effect tandem mass spectrometry Tandem Mass Spectrometry - methods ulcerative colitis Zingiber officinale |
| Title | Comparative pharmacokinetics of the main active components in normal and ulcerative colitis rats after oral administration of Zingiberis Rhizoma–Ginseng Radix et Rhizoma herb pair and its single herb extracts by LC–MS/MS |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fjssc.202101019 https://www.ncbi.nlm.nih.gov/pubmed/35474281 https://www.proquest.com/docview/2695181215 https://www.proquest.com/docview/2656202228 https://www.proquest.com/docview/2718296486 |
| Volume | 45 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELZQOQAHHuW1UKpBQuLkbpM4iX2sAqWquhw2VKq4RLbjVKHb7KrZlYAT_4E_iPglzOTVLggQQnvZXc869nrs-cae-czYCxvGeeRpj1tPOi6slVzHQvMIrbVWwohCUoLz5G10cCwOT8KTK1n8LT_EsOFGM6NZr2mCa1OPL0lDP9Q1URCiy4IvyuCjgC1CRdOBP8qjLE_yuNBsc4XguGdt3PXH6z9ft0q_QM115NqYnv07TPeNbiNOznZWS7NjP__E5_g_vbrLbne4FPZaRbrHrrlqk91I-uvgNtmtK8yF99m35JI1HBYd_fUZlhPrM8wLQFwJ57qsQDcLKlDo-ryiqA3ALytCyjPQVQ6rmXVdPbaJxasBP9bQXF4OxB8Aeo3gl2p_T9csGWKZhikFDZ7r71--vilpn_wUpjovP4Jb9kWAamlgocuL5oElVk4bJDPXFqB1okyxGswnOEqwnkk6nqQP2PH-63fJAe8ui-AWXUTFfUdHvEoZ1LEgDp0KA0pQ8XRhC2lCaekAFt-6UFghdBRHBXr_hZ-HOg-8PAgeso0K_4fHDGyMsMUomXuOCOcRMu0SkaVB3zOOjVYjxntlyWzHpE4XesyylgPaz2gUs2EUR-zlIL9oOUR-K7nV617WrSV15keIgiWxgIzY86EYR5-OdnTl5iuSQRxLvrv8gwzCEDpkl9GIPWr1emhOEArstPSwa412_qWd2WGaJmiZ1JN_lH_KblIz23jnLbaxvFi5Z4jqlmabXd97NTlKt5sZ_AMSEkwX |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3NbtNAEB5V5VA48FP-AgUGCcTJTe34bw8ckEtJ26SHpJUqLu7ueo1CUyeqE0E58Q48Ca_CEyCehBn_lYAAcegB-RJnV-v1emfnm9nZbwCeaC9IfFvalrZDY7lah5YMXGn5pK2lcJWbhnzAub_ndw_cnUPvcAk-12dhSn6IxuHGklGs1yzg7JBun7OGvs1z5iAkm4UuUcVV7pqzd2S15c-3N-kTP3WcrZf7UdeqEgtYmswJYTmGtwOFUNSfTuAZ4XX4MIMtU52Gygs1b9bRT-O52nWlH_gpWYqpk3gy6dgJ-0Bp1b_EacSZrn9z0DBW2XyulG08asESBMdrnsgNp73Y30U9-Au4XcTKhbLbugZf6mEqY1yO1-czta4__MQg-V-N43W4WkFvfFHKyg1YMtkqrER1xrtVuPIDOeNN-BqdE6PjtGL4PqZyJrbGSYoEnfFEjjKUhc5Ajs6fZByYgvRnxsbAGGWW4HysTdWOLsINc6TbHIv87MgUCSgXOIy59decSUoxkTYOOC7yRH77-OnViLcC3uBAJqP3aGZ1EZLkKZzK0WnxwBE1zj6gsSkLSAHzYbgc1Rn2ImqnP2z3h7fg4EKG-zYsZzQOdwF1QMhMiTCxDXPqEyrcYK5OReZ1ECgpWmDVszPWFVk85ywZxyXNtRPzrImbWdOCZ039aUmT8tuaa_Vkj6vlMo8dn4B-yEQnLXjcFNPX590rmZnJnOsQVGf3RPiHOoS0OI4g9FtwpxSkpjsdz6WXDm16tUIc_tLPeGc4jEj5inv_WP8RrHT3-724t723ex8uc5fL8O41WJ6dzs0DArEz9bBYNhCOLlq-vgNEN6Zn |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9NAEB5VReJx4FFegQKDBOLkpnb8WB84oITQVyqUUKnqxeyu18g0daI6EZQT_4E_wl_hHyB-CTN-lYAAcegB-RJnV-P1emfnm93ZbwAeaS-IfVvalraFsVythSUDV1o-WWsZuspNBB9wHuz6G3vu1r63vwSf67MwJT9Es-DGmlHM16zg0zhpn5KGvs1zpiAkl4WusAqr3DYn78hpy59u9ugLP3ac_vNX3Q2ryitgafImQssxvBsYhoqa0wk8E3odPstgy0QnQnlC814d_TSeq11X-oGfkKOYOLEn444d8xIoTfrnWAYni-gNG8Iqm4-VsotHEqyQ0HhNE7nutBfbu2gGf8G2i1C5sHX9K_Cl7qUyxOVwbT5Ta_rDTwSS_1M3XoXLFfDGZ6WmXIMlk63AhW6d724FLv1AzXgdvnZPadFxWvF7H1I501rjJEECzngk0wxlYTGQY_MnGYelIP2ZsSswRpnFOB9rU8nRRbBhjnSbY5GdHZkgAeUCgzFLP-A8UopptHHIUZFH8tvHTy9S3gh4g0MZp-_RzOoiJL1TOJXpcfHAlITzCtDYlAVkfvkoXI7qBHe6JGcwag9GN2DvTLr7Jixn1A-3AXVAuEyFIrYNM-oTJlxnpk5FznUQKBm2wKoHZ6QrqnjOWDKOSpJrJ-JREzWjpgVPmvrTkiTltzVX67EeVZNlHjk-wXzBNCcteNgU09fnvSuZmcmc6xBQ58UJ8Yc6hLM4ikD4LbhV6lHTnI7n0ksLm16t0Ia_tDPaGo26ZHrDO_9Y_wGcf9nrRzubu9t34SK3uIztXoXl2fHc3CMEO1P3i0kD4fVZq9d3oFulFg |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Comparative+pharmacokinetics+of+the+main+active+components+in+normal+and+ulcerative+colitis+rats+after+oral+administration+of+Zingiberis+Rhizoma-Ginseng+Radix+et+Rhizoma+herb+pair+and+its+single+herb+extracts+by+LC-MS%2FMS&rft.jtitle=Journal+of+separation+science&rft.au=Wan%2C+Yue&rft.au=Dong%2C+Zhiling&rft.au=Li%2C+Huifang&rft.au=Yang%2C+Lei&rft.date=2022-07-01&rft.issn=1615-9314&rft.eissn=1615-9314&rft.volume=45&rft.issue=13&rft.spage=2228&rft_id=info:doi/10.1002%2Fjssc.202101019&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1615-9306&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1615-9306&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1615-9306&client=summon |